Navigation Links
FDA clears new IMMY and University of Nevada, Reno life-saving blood test
Date:8/24/2011

RENO, Nev. The Food and Drug Administration has cleared a new diagnostic test that will help save the lives of hundreds of thousands of AIDS patients stricken with cryptococcosis, a fungal meningitis. The test was developed through a collaboration between Tom Kozel, professor of microbiology of the University of Nevada School of Medicine, and Sean Bauman, president and CEO of IMMY (Immuno-Mycologics) of Oklahoma.

The new, rapid blood test known as the CrAg Lateral Flow Assay leads to early diagnosis of cryptococcosis, a leading cause of AIDS-related deaths in developing countries, by detecting the cryptoccocal antigen. Using an antibody developed by Kozel, the point-of-care product is a simple dipstick test requiring no equipment.

"Our goal is to save lives," said Bauman. "With the CrAg Lateral Flow Assay, a health-care provider can give the test, observe the results, and administer the first dose of oral medication, all within a few minutesresulting in a life that has truly been changed for the better."

Current diagnostic tests for cryptococcosis are effective, but are not suitable for resource-limited settings. The tests require technical expertise, special laboratory equipment, and refrigeration for storage. All of these elements are difficult to come by for a rural clinic in a resource-limited country that lacks reliable electricity and proper infrastructure.

Kozel, who has been conducting AIDS research for more than 25 years, said studies have shown that early identification and treatment is essential to beat the disease; a late diagnosis means antifungal therapy will likely fail in resource-limited countries. Most patients in that setting are not diagnosed until they are very sick, and then it's too late.

The United States' Center for Disease Control and Prevention has published a fact sheet and established a "call to action" goal of having half of all AIDS clinics in Africa and Asia equipped by 2015 to do the testing and treatment. They estimate 50,000 to 100,000 lives will be saved every year.

The antibody used for the Cryptococcus test was developed in the lab at the Reno campus with grants from the National Institutes of Health. Bauman commercialized the technology to make it available at low cost to patients in developing countries with a licensing agreement established through the University of Nevada, Reno's Technology Transfer Office.

The IMMY product is now available in South Africa, Kenya and Uganda, and this FDA approval makes it available globally.


'/>"/>

Contact: Mike Wolterbeek
mwolterbeek@unr.edu
University of Nevada, Reno
Source:Eurekalert  

Related medicine news :

1. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
2. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
3. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Smithsonian Institution, Arizona State University announce education and research partnership
6. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
7. Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan
8. Arizona State Universitys Decision Theater offers balance to an off-kilter world
9. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
10. Herzing University Online Launches Master and Bachelor of Science Degrees in Nursing
11. Nurtur Acquires ActivHealth and Wellness by Choice; Gains Exclusive Partnership with Duke University Center for Living
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA clears new IMMY and University of Nevada, Reno life-saving blood test
(Date:8/16/2017)... ... August 16, 2017 , ... First Choice Emergency Room ... Dr. Douglas J. Harrison, as the new Medical Director of its Sienna Plantation facility. ... Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, Area Medical ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... With low back pain afflicting 8 of ... what causes its kissing cousin – upper back pain. But this equally vexing condition stems ... options, according to Kaixuan Liu, MD, PhD , founder and president of Atlantic Spine ...
(Date:8/15/2017)... ... August 15, 2017 , ... Medicine is much more than ... who feels isolated. It’s developing relationships and thereby growing the mind. It’s finding ... MD, PhD, invited three renowned authors and academic leaders – and decades-long friends ...
(Date:8/15/2017)... ... 2017 , ... The Philadelphia Marathon and the American Association for Cancer Research ... the City’s commitment to improving the health of its citizens. Dedicated to preventing and ... healthy lifestyle as research shows this can help reduce the risk of cancer. ...
(Date:8/15/2017)... ... August 15, 2017 , ... The V Foundation for Cancer ... V Foundation Wine Celebration raised nearly $9 million for cancer research during a ... “Fund-A-Need” donations to support the study of BRCA mutation research in laboratories and ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and other ... up healthcare costs and threatening outcomes, were problems taken ... and IVD industry that support them, met this week. ... researcher said that drugs of abuse, procalcitonin and acute ... at the organization,s 69th meeting in San ...
Breaking Medicine Technology: